Immediate Postplacental Insertion of Intrauterine Devices at Time of Cesarean Delivery: A Randomized Clinical Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Intrauterine Devices
- Sponsor
- University of North Carolina, Chapel Hill
- Enrollment
- 112
- Locations
- 1
- Primary Endpoint
- IUD Use
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
This is a randomized controlled trial among women who deliver by cesarean at UNC Women's Hospital and desire an Intrauterine Device (IUD) for contraception postpartum. After consenting, women will be randomized to receive an IUD at time of cesarean delivery or at a postpartum visit 4-8 weeks later. After randomization, subjects will be given a choice of the Mirena® IUD or the Paragard® IUD. Data collection will occur at baseline, delivery, the 4-8 week postpartum visit, and 2 follow-up encounters at 3 and 6 months. We hypothesize that women who receive an IUD at the time of cesarean will be more likely to use an IUD 6 months later than women who plan on receiving an IUD 4-8 weeks after delivery.
Investigators
Erika Levi, MD, MPH
Principal Investigator
University of North Carolina, Chapel Hill
Eligibility Criteria
Inclusion Criteria
- •Women ages 18-45
- •Pregnant and greater than or equal to 24 weeks of estimated gestational age
- •Live Pregnancy
- •States a plan to use an Intrauterine Device (IUD) postpartum for contraception
- •Plan for cesarean delivery
- •Intend to stay in the Chapel Hill area for at least 6 months after birth
- •Fluent in English or Spanish
Exclusion Criteria
- •known uterine anomalies
- •allergies to any component of the IUD of their choosing
- •known or suspected carcinoma of the breast
- •known acute liver disease or liver tumor (benign or malignant)
- •known or suspected uterine or cervical neoplasia
- •active pelvic inflammatory disease
- •genital bleeding of unknown etiology
- •history of solid organ transplantation
- •positive test for gonorrhea or chlamydia during this pregnancy
Outcomes
Primary Outcomes
IUD Use
Time Frame: 6 months postpartum
The use of an IUD at 6 months postpartum is the primary outcome measure
Secondary Outcomes
- Women's Satisfaction With IUDs(0-6 months postpartum)
- IUD Expulsion(0-6 months postpartum)